Accurate
Simple
Proven
Improve risk assessment to better inform your prostate biopsy decision-making.
Accurate
A blood test that more accurately detects high-grade prostate cancer.1
Stratify Risk to Improve Patient Management
- Confidently avoid biopsy or extend biopsy intervals for lower-risk patients.2
- Identify patients at high risk who need intervention or closer monitoring.
Simple
A straightforward test that’s easy to order.
- No DRE required
No additional patient information needed. Not affected by BPH medications.1,3 - Covered by Medicare
and a growing number of commercial plans.
Proven
IsoPSA is proven with Clinical Evidence.
Accepted in Guidelines:
– NCCN® Early Prostate Cancer Detection
– AUA/SUO Early Detection of Prostate Cancer
Extensive portfolio of publications in collaboration with leading academic and research institutions